Hirschsprung's disease (HSCR) and anorectal malformations (ARM) comprise a spectrum of congenital disorders that affect the distal gastrointestinal tract. HSCR is typified by aganglionosis, the ...
FIGHTING TO GET BETTER TREATMENT OPTIONS FOR A RARE CHILDHOOD CONDITION. IT’S CALLED HIRSCHSPRUNG DISEASE. THE EARLIEST SIGN IN A NEWBORN IS OFTEN CONSTIPATION. THERE ARE TREATMENTS AVAILABLE. HERE’S ...
MONTREAL--(BUSINESS WIRE)--Neurenati Therapeutics Inc., a biotech company focused on rare pediatric diseases, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted both ...
MONTREAL--(BUSINESS WIRE)--Neurenati Therapeutics Inc., a biotechnology company dedicated to developing transformative therapies for rare pediatric diseases, is pleased to announce that the European ...
A UK collaboration is advancing a first-in-class regenerative, stem cell therapy for Hirschsprung disease to reshape ...
Neurenati Therapeutics Inc.’s NEU-001 has been awarded U.S. orphan drug and rare pediatric disease designations by the FDA for the treatment of Hirschsprung disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results